Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2

doi:10.16352/j.issn.1001-6325.2024.02.0185

Abstract

Abstract: Objective To explore the mechanism of the demethylase fat mass and obesity associatal(FTO) gene on the proliferation of human liver cancer cell line HepG2. Methods HepG2 cells were divided into the control group, FTO group (transfected with FTO over-expression plasmid), si-FTO group (transfected with si-FTO)and si-FTO+si-FoxO1 group (simultaneously transfected with si-FTO and si-FoxO1). The expression of FTO in cells was detected by RT-qPCR. Cell proliferation, invasion and apoptosis were examined using CCK-8 assay, Transwell chamber assay and flow cytometry, respectively. Dot blot assay was performed to measure m⁶A methylation , and protein expression of FoxO1 in cells was detected by Western blot. Results Analysis of overall survival in liver cancer patients using The Cancer Genome Atlas (TCGA) showed higher expression of FTO associated with shorter survival (P＜0.05). Compared with normal liver cells HL7702, FTO relative expression was significantly increased in human liver cancer cells HepG2 (P＜0.05).The relative expression of FTO in si-FTO group cells was lower than that in the control group, while the relative expression of FTO in FTO group was higher than that in the control group (P＜0.05). The relative expression of FTO in the si-FTO+si-FoxO1 group was higher than that in the si-FTO group(P＜0.05). Compared with the Control group, cell viability, count of invasive cells, relative level of m⁶A were significantly decreased, while apoptosis rate and protein expression of FoxO1 were significantly increased in the si-FTO group(P＜0.05). Cell viability, count of invasive cells, and relative expression level of m⁶A were significantly higher, while apoptosis rate and protein expression of FoxO1 were significantly lower in the FTO group compared to the Control group (P＜0.05). Compared with the si-FTO group, cell viability, invasive cells and relative level of m⁶A were significantly increased, while apoptosis rate and protein expression of FoxO1 were significantly decreased in the si-FTO+si-FoxO1 group(P＜0.05). Conclusion High expression of FTO is associated with poor clinical prognosis. Knockdown of the demethylase FTO gene inhibits proliferation and invasion of liver cancer cells and induces their apoptosis. The mechanism is potentially related to the regulation of FoxO1.

Key words: demethylase, fat mass and obesity associated(FTO) protein, forkhead box protein 1(FoxO1), hepatocellular carcinoma, apoptosis

CLC Number:

R735.7

LU Huiying, WANG Jianguo. Downregulation of demethylase FTO inhibits proliferation of human liver cancer cell line HepG2[J]. Basic & Clinical Medicine, 2024, 44(2): 185-191.

References

[1]Sidali S, Trépo E, Sutter O, et al. New concepts in the treatment of hepatocellular carcinoma[J]. United European Gastroenterol J, 2022,10:765-774.
[2]Sendinc E, Shi Y. RNA m⁶A methylation across the transcriptome[J]. Mol Cell, 2023,83:428-441.
[3]Chauhdary Z, Rehman K, Akash MSH. The composite alliance of FTO locus with obesity-related genetic varia[J]. Clin Exp Pharmacol Physiol, 2021,48:954-965.
[4]Benchoula K, Arya A, Parhar IS, et al. FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity[J]. Eur J Pharmacol, 2021,891:173758. doi: 10.1016/j.ejphar.2020.173758.
[5]Ma X, Suo Z, Ma X,et al. Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma[J]. J Ethnopharmacol, 2022,296:115433. doi: 10.1016/j.jep.2022.115433.
[6]Han X, Guo J, Fan Z. Interactions between m⁶A modification and miRNAs in malignant tumors[J]. Cell Death Dis, 2021,12:598-602. doi: 10.1038/s41419-021-03868-5.
[7]Yang Z, Yu GL, Zhu X,et al. Critical roles of FTO-mediated mRNA m⁶A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders[J]. Genes Dis, 2021;9:51-61.
[8]Li M, Wu X, Li G,et al. FTO promotes the stemness of gastric cancer cells[J]. DNA Cell Biol, 2023,42:411-420.
[9]Xu D, Shao W, Jiang Y,et al. FTO expression is associated with the occurrence of gastric cancer and prognosis[J]. Oncol Rep, 2017,38:2285-2292.
[10]Li Y, Zheng D, Wang F,et al. Expression of demethylase genes, FTO and ALKBH1, is associated with prognosis of gastric cancer[J]. Dig Dis Sci, 2019,64:1503-1513.
[11]Saljooghi S, Heidari Z, Saravani M,et al. Association of FOXO1 Rs17592236 polymorphism and tumor size in papillary thyroid carcinoma[J]. Rep Biochem Mol Biol, 2022,11:216-223.
[12]Gao H, Zhou L, Zhong Y, et al. Kindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice[J]. Nat Commun,2022,13:1025-1027.doi: 10.1038/s41467-022-28692-z.
[13]Jiang J, Huang Z, Chen X, et al. Trifluoperazine activates FOXO1-related signals to inhibit tumor growth in hepatocellular carcinoma[J]. DNA Cell Biol, 2017,36:813-821.

[1]	LUO Menglin, ZHENG Feng, JI Xinyao, QI Caihong, XIAO Yuheng, NIU Changchun. Fluid shear promotes apoptosis of glomerular endothelial cells by activation of Piezo 1 [J]. Basic & Clinical Medicine, 2024, 44(9): 1236-1242.
[2]	LI Shunle, LI Rong, TIAN Yaya, RAN Xiaoli, ZHAO Yanpei, XU Meng. Association of serum KLF5 and actinin-4 levels with prognosis of TACE treatment for hepatocellular carcinoma [J]. Basic & Clinical Medicine, 2024, 44(9): 1284-1289.
[3]	WANG Tingting, WEI Huan, YANG Yongli, ZHOU Xian, HU Yang. Nervous protection provided by notoginsenoside Rg1 in rat model with Alzheimer′s disease [J]. Basic & Clinical Medicine, 2024, 44(8): 1094-1100.
[4]	GAO Chao, ZHANG Runhan, WANG Wei, ZHAO Manting, JIAO Yan, LI Zhe. Effect of artesunate on neuroinflammation in depressed mouse model by regulating cGAS-STING signaling pathway [J]. Basic & Clinical Medicine, 2024, 44(8): 1126-1132.
[5]	YU Dongling, MO Shaoe, FU Wen, CHEN Shi, XIE Chouqin, LAN Yuyan. Inhibition of sigma-1 receptor reduces DRG cell apoptosis of rats with neuropathic pain [J]. Basic & Clinical Medicine, 2024, 44(8): 1101-1106.
[6]	GAO Yinjie, TONG Anli. Mechanisms of cell death and proliferation of aldosterone-producing adenoma [J]. Basic & Clinical Medicine, 2024, 44(6): 758-762.
[7]	LI Jinping, LIU Hanqing, YANG Quanhui. Change of cell cycle in rat spleen after severe abdominal infection [J]. Basic & Clinical Medicine, 2024, 44(6): 828-832.
[8]	GONG Jintao, LI Jianwei, LI Yuheng, LI Qian, ZHAO Chunhua. Bone marrow-derived mesenchymal stem cells relieve the adverse effects of simulated microgravity on mouse cerebral cortex [J]. Basic & Clinical Medicine, 2024, 44(6): 772-778.
[9]	YANG Chunsheng, WANG Tianxing, ZHANG Tiecheng, WU Hengmin, WANG Baolan. Effects of biological clock gene Bmal1 on the expression of cell cycle-associated genes in chondrocytes [J]. Basic & Clinical Medicine, 2024, 44(4): 496-502.
[10]	YANG Kaifei, ZHU Jingge, ZHANG Yangyang, ZHAO Junguo, GAO Yuyue, HU Huanhuan, JI Guojie. Effect of sorafenib induced apoptosis and autophagy on drug resistance in HeLa cells [J]. Basic & Clinical Medicine, 2024, 44(4): 467-473.
[11]	LI Na, LI Tao, YANG Dongli, YAO Yuan. Honokiol inhibits the proliferation of human adipose-derived mesenchymal stem cells [J]. Basic & Clinical Medicine, 2024, 44(4): 483-488.
[12]	ZHANG Jing, YANG Zigeng, CAI Wenqin, CAO Weiwei, WEI Hongmei, XUE Xixi, WU Bin. Inhibition of prohibitin 2 enhances the sensitivity of non-small cell lung cancer cell line A549 to erlotinib [J]. Basic & Clinical Medicine, 2024, 44(3): 325-332.
[13]	AN Qi, QI Guangzhao, HAN Chao. Aucubin inhibits the proliferation of human hepatocellular carcinoma cells line HepG2 [J]. Basic & Clinical Medicine, 2024, 44(3): 333-338.
[14]	. Ropivacaine alleviates LPS-induced apoptosis of ulcerative colitis cell line NCM-460 [J]. Basic & Clinical Medicine, 2024, 44(10): 1368-1375.
[15]	SU Shixiang, WANG Yuyang, QIN Zongshuai, HUANG Guixiang, XU Jian, CEN Lanying, QIN Yueqiu. miR-142-3p inhibits cerulein-induced apoptosis of rat pancreatic exocrine cell line AR42J by regulating Hmgb1 [J]. Basic & Clinical Medicine, 2024, 44(1): 23-30.